P

Piramal Pharma Ltd
NSE:PPLPHARMA

Watchlist Manager
Piramal Pharma Ltd
NSE:PPLPHARMA
Watchlist
Price: 172.32 INR -1.09%
Market Cap: 227.9B INR

Intrinsic Value

The intrinsic value of one PPLPHARMA stock under the Base Case scenario is hidden INR. Compared to the current market price of 172.32 INR, Piramal Pharma Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PPLPHARMA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Piramal Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

PPLPHARMA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PPLPHARMA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PPLPHARMA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PPLPHARMA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Piramal Pharma Ltd.

Explain Valuation
Compare PPLPHARMA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PPLPHARMA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Piramal Pharma Ltd

Current Assets 59.5B
Cash & Short-Term Investments 7.7B
Receivables 19.9B
Other Current Assets 31.9B
Non-Current Assets 102.4B
Long-Term Investments 2.9B
PP&E 52.2B
Intangibles 41.7B
Other Non-Current Assets 5.6B
Current Liabilities 41.6B
Accounts Payable 18.3B
Other Current Liabilities 23.3B
Non-Current Liabilities 39.6B
Long-Term Debt 34.2B
Other Non-Current Liabilities 5.4B
Efficiency

Free Cash Flow Analysis
Piramal Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Piramal Pharma Ltd

Revenue
89.4B INR
Cost of Revenue
-31.6B INR
Gross Profit
57.8B INR
Operating Expenses
-54.5B INR
Operating Income
3.2B INR
Other Expenses
-3.5B INR
Net Income
-237.4m INR
Fundamental Scores

PPLPHARMA Profitability Score
Profitability Due Diligence

Piramal Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

Piramal Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PPLPHARMA Solvency Score
Solvency Due Diligence

Piramal Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Piramal Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PPLPHARMA Price Targets Summary
Piramal Pharma Ltd

Wall Street analysts forecast PPLPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 263.39 INR with a low forecast of 217.15 INR and a high forecast of 336 INR.

Lowest
Price Target
217.15 INR
26% Upside
Average
Price Target
263.39 INR
53% Upside
Highest
Price Target
336 INR
95% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PPLPHARMA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PPLPHARMA stock?

The intrinsic value of one PPLPHARMA stock under the Base Case scenario is hidden INR.

Is PPLPHARMA stock undervalued or overvalued?

Compared to the current market price of 172.32 INR, Piramal Pharma Ltd is hidden .

Back to Top